Literature DB >> 35882777

The Disease-Modifying Role of Taurine and Its Therapeutic Potential in Coronavirus Disease 2019 (COVID-19).

Larissa E van Eijk1, Annette K Offringa2, Maria-Elena Bernal3, Arno R Bourgonje4, Harry van Goor1, Jan-Luuk Hillebrands1.   

Abstract

Taurine is an amino sulfonic acid that is implicated in numerous physiological functions, including the regulation of oxidative stress, which plays an important role in coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), together with other pathophysiological processes. The recent finding of decreased serum taurine levels in SARS-CoV-2-infected patients, in tandem with its potential modulatory role in COVID-19 due to its antiviral, antioxidant, anti-inflammatory, and vascular-related effects, provides a rationale for considering taurine as a beneficial supplement in patients suffering from COVID-19. Here, we reviewed the potential disease-modifying effects of taurine and combined these with the current knowledge on COVID-19 to clarify the potential role of taurine in this respiratory disease.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Coronavirus disease 2019 (COVID-19); Inflammation; Oxidative stress; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Taurine; Treatment

Mesh:

Substances:

Year:  2022        PMID: 35882777     DOI: 10.1007/978-3-030-93337-1_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   3.650


  114 in total

Review 1.  Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease.

Authors:  Arno R Bourgonje; Martin Feelisch; Klaas Nico Faber; Andreas Pasch; Gerard Dijkstra; Harry van Goor
Journal:  Trends Mol Med       Date:  2020-06-30       Impact factor: 11.951

2.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.

Authors:  Maximilian Ackermann; Stijn E Verleden; Mark Kuehnel; Axel Haverich; Tobias Welte; Florian Laenger; Arno Vanstapel; Christopher Werlein; Helge Stark; Alexandar Tzankov; William W Li; Vincent W Li; Steven J Mentzer; Danny Jonigk
Journal:  N Engl J Med       Date:  2020-05-21       Impact factor: 91.245

Review 3.  Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery.

Authors:  Julius Benicky; Enrique Sánchez-Lemus; Jaroslav Pavel; Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2009-03-04       Impact factor: 5.046

4.  Taurine alleviates endoplasmic reticulum stress in the chondrocytes from patients with osteoarthritis.

Authors:  Yiqun Bian; Hao Wang; Shui Sun
Journal:  Redox Rep       Date:  2018-12       Impact factor: 4.412

5.  Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.

Authors:  Ranu Baral; Vasiliki Tsampasian; Maciej Debski; Brendan Moran; Pankaj Garg; Allan Clark; Vassilios S Vassiliou
Journal:  JAMA Netw Open       Date:  2021-03-01

6.  Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers.

Authors:  Abdul Mannan Baig
Journal:  J Med Virol       Date:  2021-03-01       Impact factor: 2.327

7.  Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus.

Authors:  Silke Bender; Antje Reuter; Florian Eberle; Evelyne Einhorn; Marco Binder; Ralf Bartenschlager
Journal:  PLoS Pathog       Date:  2015-11-20       Impact factor: 6.823

Review 8.  Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.

Authors:  Sakir Ahmed; Olena Zimba; Armen Yuri Gasparyan
Journal:  Clin Rheumatol       Date:  2020-07-11       Impact factor: 2.980

9.  COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.

Authors:  Hanny Al-Samkari; Rebecca S Karp Leaf; Walter H Dzik; Jonathan C T Carlson; Annemarie E Fogerty; Anem Waheed; Katayoon Goodarzi; Pavan K Bendapudi; Larissa Bornikova; Shruti Gupta; David E Leaf; David J Kuter; Rachel P Rosovsky
Journal:  Blood       Date:  2020-07-23       Impact factor: 25.476

Review 10.  Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).

Authors:  Arno R Bourgonje; Amaal E Abdulle; Wim Timens; Jan-Luuk Hillebrands; Gerjan J Navis; Sanne J Gordijn; Marieke C Bolling; Gerard Dijkstra; Adriaan A Voors; Albert Dme Osterhaus; Peter Hj van der Voort; Douwe J Mulder; Harry van Goor
Journal:  J Pathol       Date:  2020-06-10       Impact factor: 9.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.